Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.34% Nasdaq Up 0.16%
Streaming
Ticker Tape: On

More On BGC.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

BTG plc (BGC.L)

-LSE

0.00 0.00(0.00%) N/A

Add to Portfolio
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:398.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:N/A
Volume:0
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):0.00
EPS (ttm):0.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Headlines

  • No Headlines available for BGC.L at this time.

Comparison

Symbol% ChgMkt Cap
BGC.L 0.00%N/A
RHHBYN.MXUp 0.14%2.66T
SHP.LDown 0.75%11.69B
SUNPHARMA.NSUp 2.75%1.04T
GILD.MXUp 2.12%1.06T

Key Statistics

Forward P/E (1 yr):0.00
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-13) :13.50
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):3.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BTG plc, a specialist healthcare company, engages in developing and commercializing products targeting critical care, cancer, and other disorders. The company markets and sells specialty pharmaceuticals, including CroFab, a snake bite antivenom to... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback